Analyst consensus rating

NervGen Pharma Analyst Rating: Strong Buy

Direct answer

NervGen Pharma's consensus rating is Strong Buy.

1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $10.00.
Forecast evidence checked November 17, 2026.

Get free NervGen Pharma email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$1.82
Average price target
$10.00
High price target
$10.00
Low price target
$10.00
Low target gap
+449.5%
Target upside
+449.5%
High target gap
+449.5%
Target range width
0%
Consensus rating
Strong Buy
Analysts
1
Evidence date
November 17, 2026
Valid through
November 24, 2026

Read the frequently asked questions.

What is the analyst consensus rating for NervGen Pharma?

NervGen Pharma has a verified Strong Buy consensus. The same dataset has an average price target of $10.00.

How far are NervGen Pharma's low and high targets from the recorded price?

The low target implies +449.5%, while the high target implies +449.5%.

How many analysts are included in NervGen Pharma's consensus?

The verified consensus includes 1 analysts.

How is NervGen Pharma's target upside or downside calculated?

The average target of $10.00 is divided by the recorded price of $1.82, then one is subtracted to produce +449.5%. This does not guarantee a future return.

When was NervGen Pharma's analyst forecast verified?

The data was verified on 2026-11-17. The dataset is valid through 2026-11-24.